Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

English Title of Research Project: Effects of Dapagliflozin on Inflammatory Markers, Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD

NCT06820567 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06820567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06820567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
English Title of Research Project: Effects of Dapagliflozin on Inflammatory Markers, Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD
Lead sponsor
Assiut University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
May 1, 2027
Enrollment
210 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, diabetes type 2